By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company HilleVax, Inc.

HilleVax, Inc. (HLVX)

NASDAQ Currency in USD
$2.10
+$0.01
+0.24%
Last Update: 12 Sept 2025, 14:39
$105.05M
Market Cap
-1.33
P/E Ratio (TTM)
Forward Dividend Yield
$1.34 - $2.17
52 Week Range

HLVX Stock Price Chart

Explore HilleVax, Inc. interactive price chart. Choose custom timeframes to analyze HLVX price movements and trends.

HLVX Company Profile

Discover essential business fundamentals and corporate details for HilleVax, Inc. (HLVX) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

29 Apr 2022

Employees

14.00

CEO

Robert M. Hershberg

Description

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

HLVX Financial Timeline

Browse a chronological timeline of HilleVax, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 6 Nov 2025

EPS estimate is -$0.15.

Earnings released on 6 Aug 2025

EPS came in at -$0.11 surpassing the estimated -$0.14 by +21.43%.

Earnings released on 8 May 2025

EPS came in at -$0.12 surpassing the estimated -$0.37 by +67.57%.

Earnings released on 28 Mar 2025

EPS came in at -$0.35 falling short of the estimated -$0.33 by -6.06%.

Earnings released on 7 Nov 2024

EPS came in at -$0.52 falling short of the estimated -$0.42 by -23.81%.

Earnings released on 8 Aug 2024

EPS came in at -$0.83 falling short of the estimated -$0.73 by -13.70%.

Earnings released on 9 May 2024

EPS came in at -$0.97 falling short of the estimated -$0.84 by -15.48%.

Earnings released on 20 Mar 2024

EPS came in at -$0.78 surpassing the estimated -$0.80 by +2.50%, while revenue for the quarter reached $2.86M .

Earnings released on 9 Nov 2023

EPS came in at -$0.81 surpassing the estimated -$0.84 by +3.57%.

Earnings released on 14 Aug 2023

EPS came in at -$0.74 surpassing the estimated -$0.85 by +12.94%.

Earnings released on 12 May 2023

EPS came in at -$0.71 surpassing the estimated -$0.96 by +26.04%.

Earnings released on 17 Mar 2023

EPS came in at -$0.56 surpassing the estimated -$0.98 by +42.86%.

Earnings released on 10 Nov 2022

EPS came in at -$0.45 surpassing the estimated -$0.88 by +48.86%.

Earnings released on 10 Aug 2022

EPS came in at -$2.03 falling short of the estimated -$0.87 by -133.33%.

Earnings released on 8 Jun 2022

EPS came in at -$10.06 falling short of the estimated -$3.67 by -174.11%.

Earnings released on 29 Apr 2022

EPS came in at -$2.29 .

Earnings released on 30 Sept 2021

EPS came in at -$3.80 .

Earnings released on 30 Jun 2021

EPS came in at -$0.10 .

Earnings released on 31 Mar 2021

EPS came in at -$0.09 .

Earnings released on 31 Dec 2020

EPS came in at -$0.02 .

HLVX Stock Performance

Access detailed HLVX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run